메뉴 건너뛰기




Volumn 9, Issue 7, 2010, Pages 2152-

Variant isoforms of BCR-ABL1 in chronic myelogenous leukemia reflect alternative splicing of ABL1 in normal tissue - Letter

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; ISOPROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; ABELSON KINASE; ANTINEOPLASTIC AGENT;

EID: 77954570602     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0311     Document Type: Letter
Times cited : (5)

References (6)
  • 1
    • 57749110998 scopus 로고    scopus 로고
    • BCR-ABL alternative splicing as a common mechanism for imatinib resistance: Evidence from molecular dynamics simulations
    • Lee TS, Ma W, Zhang X, et al. BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations. Mol Cancer Ther 2008;7:3834-41.
    • (2008) Mol Cancer Ther , vol.7 , pp. 3834-3841
    • Lee, T.S.1    Ma, W.2    Zhang, X.3
  • 2
    • 77949759754 scopus 로고    scopus 로고
    • ABL alternative splicing is quite frequent in normal population-letter
    • Santamaria I, Pitiot AS, Balbin M. ABL alternative splicing is quite frequent in normal population-letter. Mol Cancer Ther 2010;9:772.
    • (2010) Mol Cancer Ther , vol.9 , pp. 772
    • Santamaria, I.1    Pitiot, A.S.2    Balbin, M.3
  • 3
    • 77949765312 scopus 로고    scopus 로고
    • BCR-ABL1INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment-response
    • Lee T-S, Ma W, Zhang X, et al. BCR-ABL1INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment-response. Mol Cancer Ther 2010;9:772.
    • (2010) Mol Cancer Ther , vol.9 , pp. 772
    • Lee, T.-S.1    Ma, W.2    Zhang, X.3
  • 4
    • 33750344192 scopus 로고    scopus 로고
    • A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib [10]
    • DOI 10.1038/sj.leu.2404400, PII 2404400
    • Gruber FX, Hjorth-Hansen H, Mikkola I, Stenke L, Johansen T. A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib. Leukemia 2006;20:2057-60. (Pubitemid 44614904)
    • (2006) Leukemia , vol.20 , Issue.11 , pp. 2057-2060
    • Gruber, F.X.1    Hjorth-Hansen, H.2    Mikkola, I.3    Stenke, L.4    Johansen, T.5
  • 5
    • 45149093418 scopus 로고    scopus 로고
    • Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia
    • Sherbenou DW, Hantschel O, Turaga L, et al. Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Leukemia 2008;22:1184-90.
    • (2008) Leukemia , vol.22 , pp. 1184-1190
    • Sherbenou, D.W.1    Hantschel, O.2    Turaga, L.3
  • 6
    • 34248368920 scopus 로고    scopus 로고
    • The implications of alternative splicing in the ENCODE protein complement
    • Tress ML, Martelli PL, Frankish A, et al. The implications of alternative splicing in the ENCODE protein complement. Proc Natl Acad Sci 2007;104:5495-500.
    • (2007) Proc Natl Acad Sci , vol.104 , pp. 5495-5500
    • Tress, M.L.1    Martelli, P.L.2    Frankish, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.